Literature DB >> 6179614

Comparative permeability of different glioma models to horseradish peroxidase.

D R Groothuis, J M Fischer, N A Vick, D D Bigner.   

Abstract

Seven different experimental glioma models were studied to determine their capillary permeability to horseradish peroxidase. The models were the autochthonous ASV-viral model, intracerebral (ic) and (sc) injections of rat 9L and RG-2 tumor cell lines, the sc rat S-69C15 tumor cell line, and human glioblastoma cell lines in nude mice. The ASV-viral model showed an average HRP permeability of 63% of tumor volume, the ic RG-2 tumors were 100% permeable, and the ic 9L tumors were 41% permeable. The permeability of the marginal zone (brain-tumor interface) showed similar variation from group to group. In contrast, all of the sc tumors were 100% permeable regardless of the cell line used to create the tumors. Our results show the variability between these glioma models, and suggest that RG-2 ic gliomas and all sc gliomas should be optimal to assess the tumoricidal effect of drugs, because access to the tumor compartment from the vascular compartment is complete.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6179614

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  20 in total

1.  Intracarotid infusion of PCNU (NSC: 95466): preclinical toxicological study in dogs.

Authors:  L Goumnerova; M T Richard; D Addison; V Montpetit; D J Stewart
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

2.  Correlation of neuropathologic findings, computerized tomographic and high-resolution ultrasound scans of canine avian sarcoma virus-induced brain tumors.

Authors:  R H Britt; B E Lyons; D R Enzmann; E L Saxer; S H Bigner; D D Bigner
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 3.  A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.

Authors:  D J Stewart
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Human central nervous system pharmacology of pentamethylmelamine and its metabolites.

Authors:  D J Stewart; J A Benvenuto; M Leavens; R G Smith; F Cabanillas; R S Benjamin; T L Loo
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

5.  Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.

Authors:  J D Heiss; E Papavassiliou; M J Merrill; L Nieman; J J Knightly; S Walbridge; N A Edwards; E H Oldfield
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

6.  Penetration of teniposide (VM-26) into human intracerebral tumors. Preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with amphotericin B or oral glycerol.

Authors:  D J Stewart; M T Richard; H Hugenholtz; J Dennery; D Nundy; J Prior; V Montpetit; H S Hopkins
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

7.  In vivo measurement of regional brain and tumor pH using [14C]dimethyloxazolidinedione and quantitative autoradiography. II: Characterization of the extracellular fluid compartment using pH-sensitive microelectrodes and [14C]sucrose.

Authors:  J B Arnold; R P Kraig; D A Rottenberg
Journal:  J Cereb Blood Flow Metab       Date:  1986-08       Impact factor: 6.200

8.  Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors.

Authors:  D J Stewart; M T Richard; H Hugenholtz; J M Dennery; R Belanger; J Gerin-Lajoie; V Montpetit; D Nundy; J Prior; H S Hopkins
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

9.  Central nervous system pharmacology of Baker's antifolate (NSC139105) in man.

Authors:  D J Stewart; M Leavens; K Lu; Y M Wang; R S Benjamin; D H Ho; H Y Yap; T L Loo
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

10.  Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy.

Authors:  Henry Hirschberg; Francisco A Uzal; David Chighvinadze; Michelle J Zhang; Qian Peng; Steen J Madsen
Journal:  Lasers Surg Med       Date:  2008-10       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.